Guo SP - Search Results

1

Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Chen NB, Li QW, Zhu ZF, Wang YM, Cheng ZJ, Hui ZG, Guo SP, He HQ, Wang B, Huang XY, Li JB, Guo JY, Hu N, Ai XL, Zhou Y, Wang DQ, Liu FJ, Xie CM, Qiu B, Liu H. Chen NB, et al. Among authors: guo jy, guo sp. Radiat Oncol. 2020 Nov 10;15(1):260. doi: 10.1186/s13014-020-01704-2. Radiat Oncol. 2020. PMID: 33168045 Free PMC article.

2

Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.

Xi M, Zhang L, Zhao L, Li QQ, Guo SP, Feng ZZ, Deng XW, Huang XY, Liu MZ. Xi M, et al. Among authors: guo sp. PLoS One. 2013 May 30;8(5):e63864. doi: 10.1371/journal.pone.0063864. Print 2013. PLoS One. 2013. PMID: 23737955 Free PMC article.

3

Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.

Chang H, Gao J, Xu BQ, Guo SP, Lu RB, Li G, Huang SM, Han F, Liu ZG, Tao YL, Tu ZW, Chen C, Li XH, Xia YF. Chang H, et al. Among authors: guo sp. Clin Oncol (R Coll Radiol). 2013 Nov;25(11):639-46. doi: 10.1016/j.clon.2013.07.004. Epub 2013 Jul 31. Clin Oncol (R Coll Radiol). 2013. PMID: 23910226

4

Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma.

Feng HX, Guo SP, Li GR, Zhong WH, Chen L, Huang LR, Qin HY. Feng HX, et al. Among authors: guo sp. Med Oncol. 2014 Sep;31(9):170. doi: 10.1007/s12032-014-0170-x. Epub 2014 Aug 15. Med Oncol. 2014. PMID: 25119503

5

Prognosis of Fibrosarcoma in Patients With and Without a History of Radiation for Nasopharyngeal Carcinoma.

Zhang P, Zhao L, Zhu YJ, Qiu B, Guo SP, Li Y, Liu Q, Liu MZ, Xi M. Zhang P, et al. Among authors: guo sp. Ann Surg Oncol. 2017 Feb;24(2):434-440. doi: 10.1245/s10434-016-5589-1. Epub 2016 Sep 21. Ann Surg Oncol. 2017. PMID: 27654106

6

Subjective Global Assessment (SGA) Score Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients With Normal Pulmonary Function Treated by Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy.

Ma L, Ye W, Li Q, Wang B, Luo G, Chen Z, Guo S, Qiu B, Liu H. Ma L, et al. Clin Lung Cancer. 2018 Mar;19(2):e211-e217. doi: 10.1016/j.cllc.2017.09.001. Epub 2017 Sep 19. Clin Lung Cancer. 2018. PMID: 29017827

7

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.

Ma L, Qiu B, Zhang J, Li QW, Wang B, Zhang XH, Qiang MY, Chen ZL, Guo SP, Liu H. Ma L, et al. Among authors: guo sp. Chin J Cancer. 2017 Dec 11;36(1):93. doi: 10.1186/s40880-017-0261-0. Chin J Cancer. 2017. PMID: 29228994 Free PMC article.

8

Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies.

Zhou S, Liu S, Zhang L, Guo S, Shen J, Li Q, Yang H, Feng Y, Liu M, Lin SH, Xi M. Zhou S, et al. Ann Surg Oncol. 2018 Nov;25(12):3639-3646. doi: 10.1245/s10434-018-6736-7. Epub 2018 Sep 7. Ann Surg Oncol. 2018. PMID: 30194608

9

Comparison of hyper- and hypofractionated radiation schemes with IMRT technique in small cell lung cancer: Clinical outcomes and the introduction of extended LQ and TCP models.

Li QW, Qiu B, Wang B, Zhang J, Chen L, Zhou Y, Qin JK, Guo SP, Xie WH, Hui ZG, Liang Y, Guo JY, Wang H, Zhu M, Shen WT, Duan LY, Chen LK, Zhang L, Long H, Wang YM, Liu H. Li QW, et al. Among authors: guo jy, guo sp. Radiother Oncol. 2019 Jul;136:98-105. doi: 10.1016/j.radonc.2019.03.035. Epub 2019 Apr 15. Radiother Oncol. 2019. PMID: 31015136

10

Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.

Wu Y, Chen J, Zhao L, Li Q, Zhu J, Yang H, Guo S, Xi M. Wu Y, et al. Cancer Res Treat. 2021 Jan;53(1):172-183. doi: 10.4143/crt.2020.594. Epub 2020 Sep 4. Cancer Res Treat. 2021. PMID: 32898941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters